. The generation and genotyping of global Camkkβ null, Lkb1 flox and POMC-Cre mice have been previously described (12,16,17). Mice with loxP sites flanking exon 5 of Camkkβ gene were generated from targeted ES cells described by Peters et al. (16) after the removal of the floxed neomycin selection gene. Genotyping was performed by PCR using genomic DNA isolated from tails. Wild-type and floxed alleles were detected using the primers 5'-TTTTACAGATGGTCTAGCGTC-3' and 5'-TTGGGGAATGTGGAATAGGC-3'. Heterozygote Camkkβ null mutants were intercrossed to generate homozygotes and wild-type littermates. Mice with loxP sites flanking exon 5 of Camkkβ were bred with POMC-Cre mice to generate compound heterozygote mice. 
(PomcLkb1KO) mice. To generate mice lacking floxed alleles but expressing GFP in cells harbouring the deletion event, mice were intercrossed with Z/EG indicator mice (18) and bred to homozygosity for the floxed allele. Mice were maintained on a 12-h light/dark cycle with free access to water and standard mouse chow (4% fat, RM1, Special Diet Services) and housed in specific-pathogen free barrier facilities. Mice were handled and all in vivo studies performed in accordance to the Animal Scientific Procedures Act (1986) . Diets. High-fat diet administration was performed as described (4). Low-fat (11%) and high-fat (58%) Surwit diets (9) were purchased from TestDiet (Richmond, IL) and administered from weaning (at 3 weeks of age) for 17 weeks. Metabolic studies. Body weights were determined weekly. Blood samples were collected from mice via tail vein or trunk bleeds using a capillary blood collection system (Sarstedt, Nümbrecht, Germany). Blood glucose was measured using a Glucometer Elite (Bayer Corporation, Haywards Heath, UK). Plasma insulin levels were analyzed using a mouse insulin ELISA from Linco (St. Charles, MI). Glucose (2 g /kg, i.p.) and pyruvate (2 g/kg, i.p.) tolerance tests were performed on overnight fasted (16h) mice and blood glucose levels determined at the indicated time points. Insulin tolerance tests were performed on randomly fed animals at 14.00h with 0.75 IU/kg of soluble insulin injected i.p. and blood glucose levels determined as above. Plasma corticosterone was measured using the Octeia Corticosterone enzymeimmunoassay from IDS (Frankfurt am Main, Germany). Feeding studies and MT-II treatment. Mice were singly housed and acclimatised for at least 1-week prior to study. When required, and prior to the study protocol, mice were acclimatised by subjecting them to overnight fasts and sham injections. Food intake was measured for 5 consecutive days. For fasting-refeeding studies, mice were overnight fasted and refed with a pre-weighed amount of food. Food intake was measured at the indicated time points. For MT-II studies, overnight fasted mice were injected with 50 µg of MT-II (Bachem UK Ltd., St. Helens, UK) or vehicle at 08.00h and food intake monitored. Measurement of resting metabolic rate. Resting metabolic rate was measured at housing temperature using an Oxymax open circuit respirometry system (Columbus Instruments, Columbus, OH). In vivo glucose-stimulated insulin secretion (GSIS) and pancreatic morphometric analysis. In vivo GSIS was performed in mice after an overnight fast. Glucose (3 g/ kg, i.p.) was injected and blood samples obtained 0, 2, 5 and 20 min post-injection. Insulin levels were assessed using a mouse ELISA kit from Linco. For pancreatic morphometry analysis, pancreases were removed, cleaned of fat and lymph nodes and fixed in Bouin´s solution. Afterwards the specimens were embedded in paraffin and cut into 5-µm sections. Insulin immunostaining and morphometric analysis were performed as previously described (21).
Insulin sensitivity and hepatic glucose production. Euglycemic-hyperinsulinemic clamps were performed as previously described (29, 20) . Briefly, D-( 3 H)3-glucose was infused at a rate of 30 µCi/kg/min and insulin at a rate of either 4 mU/kg/min or 18 mU/kg/min for 3h. Low insulin infusions were used to assess hepatic insulin sensitivity while high insulin was used to assess whole-body insulin sensitivity. Euglycemia was maintained by variable infusion of 15% glucose. Plasma glucose concentrations and D-( 3 H)3-glucose specific activity were determined in 5 µl of blood sampled from the tip of the tail. Immune complex kinase assays. Activity assays for AMPK and CaMKKβ were performed as previously described (4, 7). Hypothalamic immunohistochemistry (IHC). Rabbit anti-POMC precursor antibody (Phoenix Pharmaceuticals Inc., Belmont, CA), rabbit anti-LKB1 antibody (Upstate) and sheep anti-alpha MSH antibody (Chemicon) were used at 1:1000, 1:500 and 1:40,000, respectively. As secondary antibodies we used chicken anti-rabbit or donkey anti-sheep Alexa Fluor 488 and 594 (Molecular Probes). Imaging was performed with an Olympus BX51 microscope (Olympus UK Ltd., Southall, UK) with a Hamamatsu 95 camera combined with SimplePCI capture and deconvolution software. Confocal microscopy was performed using a BioRad TE300. Integrated density was quantitated using ImageJ software (National Institutes of Health, USA). POMC neuron counts and area. Brains from controls and mutant mice were processed and cut in 25-µm coronal sections on a microtome as described (4). Quantitative RT-PCR analysis. qRT-PCR was performed as previously described (21). Proprietary sequence Taqman Gene Expression assay FAM/TAMRA primers (Applied Biosystems, Foster City, CA) were used: Neurons were visualized in the ARC by video-enhanced differential interference contrast microscopy and the expression and excitation of GFP was used to identify POMC neurons. Whole-cell recordings were made at ~33 °C using a modified external solution containing 2 mM glucose with CaCl 2 (0.5 mM) and MgCl 2 (2.5 mM) concentrations adjusted to reduce synaptic activity. Current-clamp recordings (I fast ) were made using borosilicate glass pipettes (4-8 MΩ) containing (in mM) Kgluconate 130, KCl 10, EGTA 0.5, NaCl 1, CaCl 2 0.28, MgCl 2 3 and Hepes 10 (pH 7.2). Perforated patch was achieved by the addition of 2 to 4 µg/ml of gramicidin-D and 80 to 100 µg/ml of amphotericin-B to the patch pipette solution, as described previously (4). Whole-cell series and input resistance was continuously monitored in current-clamp by periodic hyperpolarizing pulses (5-15 pA, 200 ms duration, 0.05 Hz). Samples of membrane potential that were devoid of action potentials and obvious synaptic activity were measured from 2-5 minute stretches of data to obtain a sample mean. To avoid statistical bias, all recordings (responsive and non-responsive) from a given neuronal population were used to determine statistical significance and obtain a mean ± standard error.
Supplementary Figure 1. Gene targeting strategy for the generation of Camkkβ floxed mice. A:
Schematic diagram showing the targeting strategy used for the generation of Camkkβ floxed mice. LoxP sites flanking exon 5 of mouse Camkkβ gene were introduced. Bars indicate exons, triangles loxP sites. B, BamHI site. B: The mutation was confirmed by Southern blot analysis. An internal probe (I3 probe) was used to detect a 4.9 kb fragment in homozygous floxed mutants, whereas the wild-type allele showed a band at 4.7 kb. Supplementary Figure 2 . Camkkβ deletion, neuron integrity and hypothalamic anatomical studies in PomcCamkkβKO mice. A: Detection of deletion of Camkkβ allele in PomcCamkkβKO mice. DNA was extracted from different tissues (Hy, hypothalamus; C, cerebral cortex; L, liver; F, fat; M, skeletal muscle; H, heart; K, kidney) and recombination of the floxed Camkkβ allele detected by PCR. Recombination was only detected in the hypothalamus of PomcCamkkβKO mice. Interleukin-2 (Il-2) internal control PCR reaction is also shown. B: Representative images of hypothalamic sections from control and PomcCamkkβKO mice . POMC staining (red) is shown. C: POMC neuron counts and (D) distribution throughout the ARC in control and PomcCamkkβKO mice (n = 2-3). 3V: third ventricle. All values are mean ± SEM.
Supplementary Figure 3. Unaltered energy and glucose homeostasis in PomcCamkkβKO mice. A:
Weight curves of control (n = 27) and PomcCamkkβKO (n = 31) male mice on chow diet. B: Daily food intake under ad libitum conditions (n = 6-7) and (C) cumulative 24h food intake after a fast-refeeding test in 12 week-old control and PomcCamkkβKO male mice (n = 6-7). D: Fasted and randomly fed blood glucose levels (n = 22-31). E: Glucose and (F) insulin tolerance tests in control and PomcCamkkβKO male mice (n = 5-10). All values are mean ± SEM.
Supplementary Figure 4. Unaltered energy and glucose homeostasis in PomcCamkkβKO mice. A:
Basal metabolic rate and (B and C) MT-II test in control and PomcCamkkβKO male mice (n = 6-7). D: Plasma insulin levels in 12-week old control and PomcCamkkβKO male mice (n = 12-17). E: Pyruvate tolerance test in control and PomcCamkkβKO male mice (n = 5-10). All values are mean ± SEM. * P < 0.05, ** P < 0.01. Figure 8 . Unaltered glucose metabolism in male PomcLkb1KO mice. A: Fasted and randomly-fed blood glucose concentrations in control, hypomorphic and PomcLkb1KO male mice (n = 7-10). B: Glucose tolerance test in control, hypomorphic and PomcLkb1KO male mice (n = 7-10). All values are mean ± SEM. Supplementary Figure 9 . Normal pancreatic islet architecture, beta-cell mass and function in female PomcLkb1KO mice. Representative images of pancreatic islets with immunostainig for insulin (A) and quantified pancreatic β-cell area (B) from control, hypomorphic and PomcLkb1KO female mice (n = 3). C: Glucose-stimulated insulin secretion in control, hypomorphic and PomcLkb1KO female mice (n = 7-11). All values are mean ± SEM. Supplementary Figure 10 . Unaltered expression pattern of a panel of metabolic genes in tissues from female PomcLkb1KO mice. Expression analysis of key white adipose tissue (A) and skeletal muscle (B) genes in control, hypomorphic and PomcLkb1KO female mice (n = 10-12) assessed by qRT-PCR and expressed relative to controls. Probes for either Gapdh or Hprt were used to adjust for total RNA content. All values are mean ± SEM.
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